Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
National Resh Corp (NRC) delivers actionable healthcare experience insights through advanced analytics and proprietary methodologies. This news hub provides investors and industry professionals with essential updates on strategic initiatives shaping patient care innovation.
Access real-time press releases covering earnings disclosures, partnership announcements, and operational developments. Our curated feed simplifies tracking NRC's progress in transforming healthcare interactions through data-driven solutions.
Discover updates on key focus areas including patient engagement metrics, employee experience enhancements, and analytics platform innovations. Content is organized chronologically for efficient monitoring of NRC's market position and industry leadership.
Bookmark this page for streamlined access to verified NRC developments. Combine our updates with Stock Titan's financial tools to analyze the company's performance in healthcare experience optimization.
NRC Health has appointed Parul Bhandari, a Microsoft executive, to its Board of Directors as of May 19, 2022. Bhandari brings over 20 years of experience in technology and digital transformation, focusing on leveraging data and AI for healthcare improvement. Her role will enhance NRC's mission to foster Human Understanding in healthcare. With a solid background in business development and strategy, Bhandari aims to address the challenges of balancing technology with human-centric care delivery.
National Research Corporation (NASDAQ:NRC) reported an 8% revenue increase in Q1 2022, reaching $38.4 million compared to $35.5 million in Q1 2021. However, operating income fell by 3% to $11.7 million, and net income decreased to $8.5 million from $9.2 million year-over-year. Diluted earnings per share dropped to $0.34, down from $0.36. The company is focused on organic growth, enhancing core offerings like the Human Understanding Program, while also investing in innovation and employee benefits. Cash flow from operations decreased to $8.3 million, but net cash rose to $21.8 million.
NRC Health (NASDAQ:NRC) will host a first quarter earnings conference call on May 4, 2022, following the release of financial results after market close on May 3, 2022. The conference call will start at 11:00 a.m. ET and will be available via a live audio webcast. A replay will be accessible for 30 days after the event. NRC Health has been dedicated to enhancing human understanding in healthcare for over 40 years, focusing on improving key experiences that build trust between healthcare organizations and their clients.
NRC Health released its 2022 Pediatric Consumer Trends Report, highlighting the evolving needs of pediatric consumers post-COVID. Key findings indicate a 135% increase in parents resuming healthcare services since 2020, a 5.2% rise in telehealth adoption, and a 163% surge in mental health hospitalizations among youth. Despite these trends, pediatric marketing recall remains stagnant at 1.5%, and the Net Promoter Score for pediatric services has declined from 69 in April 2020 to 53 in December 2021. The report underscores the importance of addressing these challenges in pediatric healthcare.
NRC Health announced a quarterly cash dividend of $0.24 per share, payable on April 15, 2022. Shareholders of record as of March 31, 2022 will receive this dividend. NRC Health, a leader in analytics and insights for over 40 years, focuses on measurement and enhancement of Human Understanding.
National Research Corporation (NASDAQ:NRC) reported strong Q4 2021 results, with a 10% revenue increase to $38.3 million and a 26% operating income rise to $12.9 million, resulting in an operating margin of 34%. For the full year, revenue was $148.0 million (+11%) and operating income was $50.3 million (+18%). Diluted EPS increased to $0.38 in Q4 and $1.46 for the year. The launch of the Human Understanding Program aims to enhance personalized care across healthcare systems. The company's cash flow from operations grew to $46.3 million, boosting net cash to $27.8 million.
National Research Corporation (NASDAQ:NRC) will host a web simulcast for its 2021 fourth quarter earnings conference call on February 9, 2022, at 11:00 a.m. ET. The earnings results will be disclosed after market close on February 8, 2022. A replay of the live broadcast will be available for 30 days following the event. For over 40 years, NRC has been a leader in providing analytics and insights to enhance patient and employee experiences, aiming to improve customer engagement and loyalty in the healthcare sector.
National Research Corporation (NASDAQ:NRC) announced a quarterly cash dividend of $0.12 per share, payable on January 14, 2022. Shareholders recorded by the close of business on December 30, 2021 will qualify for this payment. The corporation has been a prominent provider of analytics and insights aimed at enhancing human understanding for over 40 years.
NRC Health has awarded the 2021 Rising Stars Scholarship to Hunter Bergman and Lauren Lewis, both students at the University of Nebraska-Lincoln. Each recipient will receive $2,000 for the spring 2022 semester. The scholarship aims to support students interested in business development, marketing, and entrepreneurship. Hunter, a senior marketing major, is the President of StartupsUNL, while Lauren is a junior marketing major and has worked on campaigns for international non-profits. The program, initiated in 2011, highlights NRC Health's commitment to education and student engagement.
FAQ
What is the current stock price of National Resh (NRC)?
What is the market cap of National Resh (NRC)?
